phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Last month, the PhRMA Foundation announced the recipients of the inaugural Challenge Awards at Morning Consult. These awards recognize the best and the brightest that are identifying transformative solutions to measure value in health care and advance a value-driven health care system. The Challenge Awards are the first phase in the multi-year Value Assessment Initiative that will award over $1 million to advance the field of value assessment.

Recipients of the PhRMA Foundation 2017 Challenge Awards are:

TIED FOR FIRST PLACE:

  • A Framework for Measuring Low-Value Care, Altarum
    • It has been estimated that more than 30 percent of health care spending in the U.S. is wasteful. Low-value care, which drives up costs unnecessarily while increasing patient risk, is a significant component of this wasteful spending. Altarum’s winning paper summarizes and critiques existing methods that measure low-value care and describes an integrated framework that combines multiple methods to comprehensively estimate and track the magnitude and principal sources of clinical waste.
  • Improving Value for Eczema Patients, National Eczema Association
    • With the cost of chronic diseases now representing a majority of spending in the United States health care system, a reliable model to measure value is critical to identify replicable improvement methods. The National Eczema Association’s (NEA) plan to establish a Shared Decision Making Resource Center is a transformative strategy that can evaluate value of health care interventions for eczema patients to advance a value-driven health care system in the U.S.

SECOND PLACE:

  • Emerging Good Practices for Transforming Value Assessment: Patients’ Voices, Patients’ Values, National Health Council and The University of Maryland School of Pharmacy
    • Most U.S. value frameworks and subsequent assessments are developed with little to no patient engagement. The National Health Council (NHC) started a value workgroup in 2016 to change this. In the past two years, patient advocacy group engagement with value framework developers and assessors has increased, with groups reporting both positive experiences and challenges in their interactions. The NHC will use these early experiences can help recommend emerging good practices that can eventually get the field to implement standards for patient engagement.

THIRD PLACE:

  • Patient Report Outcome Measures to Advance a Value-Driven Health Care System, University of Michigan
    • Patient reported outcome measures (PROMs) are tools that assess patient perspectives on their health without interpretation by any other parties, and they are key tools in clinical research. The integration of electronically-delivered PROMs in clinical practices can dramatically change health outcomes by influencing decision-making. The authors of this paper propose that the implementation of generic and disease/condition specific PROMs across health care systems will advance a value-driven health care system.

Presentations from the Challenge Awards winners are available here. For more information on the PhRMA Foundation’s Value Assessment Initiative, please visit http://www.phrmafoundation.org/2018-awards/value-assessment-initiative

Eileen Cannon

Eileen is the former president of the PhRMA Foundation. After 22 years leading the Foundation, she retired in October 2021.

Eileen Cannon

Author Twitter

Author LinkedIn

PhRMA Foundation celebrates 60 years of investing in future scientific leaders

June 11, 2025

Incomplete evaluations undermine patient access to transformational medicine

October 5, 2023

3 things about the PhRMA Foundation

May 15, 2023

Innovative contracts continue to gain traction and improve quality of care

May 2, 2022

PhRMA Foundation recognizes inaugural Challenge Award recipients

PhRMA Foundation

Value-Driven Health Care

PhRMA Foundation recognizes inaugural Challenge Award recipients

October 6, 2017

PhRMA Foundation recognizes inaugural Challenge Award recipients

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list